Bio-Research Pharma

BioResearch Pharma is a Polish clinical-stage biotechnology company specializing in the development of novel topical dermatological treatments through drug repurposing. The company's strategy involves identifying established active pharmaceutical ingredients with proven safety profiles and applying them to new therapeutic indications, thereby significantly reducing development costs and timelines. Its lead candidate, BRP-011, is a prostaglandin analogue being developed for the treatment of androgenetic alopecia, while BRP-007 is a topical anti-inflammatory agent targeting plaque psoriasis and atopic dermatitis. Both programs have demonstrated clinical proof of concept and are supported by a robust international patent portfolio. BioResearch Pharma is headquartered in Warsaw and has secured funding from prominent Polish venture capital firms and private investors.